Form 4 for CRL Charles River Laboratories
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-04 · accession 0001127602-24-008566 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-05 | 2024-03-04 | CRL | Knell Michael Gunnar | CAO, CSVP | S - Sale | $261.05 | -2,750 | 8,832 | -24% | -$717.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | S | D | 1,000 | $261.35 | 7,832 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $261.31 to $261.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-03-04 | S | D | 1,750 | $260.88 | 8,832 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $260.15 to $260.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |